| | | OCN | hsCRP | IgE | | Median | β | (95% CI) | | β | (95% CI) | |
| Metabolic syndrome | | | | | | | | | No (<3 components) | 1851 | 23.42 (19.15–29.18) | −0.009 | (−0.020, 0.002) | 0.093 | −0.02 | (−0.027, −0.008) | <0.001 | Yes (≧3 components) | 192 | 19.63 (16.75–23.67) | −0.046 | (−0.088, −0.004) | 0.032 | 0.002 | (−0.029, 0.033) | 0.893 | Hypertriglyceridemia | | | | | | | | | No (TG <1.7 mmol/L) | 1481 | 23.81 (19.47–29.46) | −0.01 | (−0.021, 0.002) | 0.096 | −0.02 | (−0.030, −0.009) | <0.001 | Yes (TG ≧1.7 mmol/L) | 562 | 21.03 (17.53–26.07) | −0.021 | (−0.046, 0.006) | 0.126 |
−0 | (−0.021, 0.015) | 0.747 | Hyperglycemia | | | | | | | | | No (GLU <5.6 mmol/L) | 1492 | 23.71 (19.525–29.41) | −0.003 | (−0.015, 0.009) | 0.608 | −0.02 | (−0.030, −0.009) | <0.001 | Yes (GLU ≧5.6 mmol/L) | 551 | 21.03 (17.57–26.34) | −0.039 | (−0.059, −0.018) | <0.001 | −0.01 | (−0.025, 0.011) | 0.454 | Elevated BP | | | | | | | | | No (<130/85 mmHg) | 1838 | 23.37 (19–29.09) | −0.013 | (−0.024, −0.002) | 0.022 | −0.02 | (−0.025, −0.006) | 0.001 | Yes (≧130/85 mmHg) | 205 | 20.81 (17.39–25.68) | −0.006 | (−0.040, 0.029) | 0.752 | −0.02 | (−0.046, 0.008) | 0.167 | Low HDL-c | | | | | | | | | No (≧1.03 mmol/L) | 1894 | 23.22 (18.84–29.04) | −0.011 | (−0.021, 0.001) | 0.057 | −0.02 | (−0.026, −0.007) | <0.001 | Yes (<1.03 mmol/L) | 149 | 20.92 (18.47–24.05) | −0.014 | (−0.055, 0.023) | 0.488 | −0 | (−0.043, 0.039) | 0.928 | Central obesity | | | | | | | | | No (WC <90 cm) | 1687 | 23.64 (19.45–29.39) | −0.01 | (−0.021, 0.001) | 0.075 | −0.02 | (−0.026, −0.006) | 0.002 | Yes (WC ≧90 cm) | 356 | 19.86 (16.84–24.88) | −0.022 | (−0.052, 0.008) | 0.158 | −0.01 | (−0.032, 0.012) | 0.365 | Obesity according to BMI | | | | | | | | | <27.5 kg/m2 | 1821 | 23.38 (19.07–29.14) | −0.009 | (−0.020, −0.002) | 0.096 | −0.02 | (−0.025, −0.006) | 0.002 | ≧27.5 kg/m2 | 222 | 20.69 (16.6–24.37) | −0.039 | (−0.075, −0.002) | 0.039 | −0.01 | (−0.038, 0.015) | 0.394 | Premetabolic syndrome | | | | | | | | | None | 967 | 25.17 (20.67–31.27) | <0.001 | (−0.015, 0.014) | 0.945 | −0.02 | (−0.031, −0.005) | 0.005 | 1 component | 574 | 22.21 (18.07–27.57) | −0.031 | (−0.051, −0.012) | 0.002 | −0.02 | (−0.037, −0.003) | 0.02 | ≧2 components | 310 | 20.61 (17.38–24.91) | 0.002 | (−0.030, 0.034) | 0.892 | −0.01 | (−0.030, 0.018) | 0.623 | Prediabetes | | | | | | | | | NGT (GLU <5.6 mmol/L) | 1796 | 23.71 (19.53–29.41) | −0.004 | (−0.016, 0.008) | 0.529 | −0.02 | (−0.029, −0.008) | <0.001 | IFG (GLU = 5.6–7.0 mmol/L) | 558 | 21.43 (17.94–26.86) | −0.035 | (−0.057, −0.014) | 0.001 | 0.002 | (−0.017, 0.021) | 0.84 | Unknown diabetes (GLU >7.0 mmol/L) | 70 | 18.42 (15.47–22.7) | −0.036 | (−0.103, 0.031) | 0.285 | −0.05 | (−0.103, 0.008) | 0.093 |
|
|
Adjusted for age, BMI, insulin, smoking status, and alcoholic drinking behavior. OCN: osteocalcin, hsCRP: high sensitive C-reaction protein, TG: triglycerides, GLU: fasting glucose, BP: blood pressure, HDL-c: high density lipoprotein cholesterol, WC: waist circumference, BMI: body mass index, NGT: normal glucose tolerance, and IFG: impaired fasting glucose.
|